Amanote Research

Amanote Research

    RegisterSign In

Assessing the Safety of New Arthritis Drugs: Are We There Yet?

Journal of Rheumatology - Canada
doi 10.3899/jrheum.080878
Full Text
Open PDF
Abstract

Available in full text

Categories
RheumatologyAllergyImmunology
Date

December 1, 2008

Authors
SAMY SUISSA
Publisher

The Journal of Rheumatology


Related search

Precision Medicine in Rheumatoid Arthritis: Are We There Yet?

Clinical Rheumatology
MedicineRheumatology
2019English

Predicting Delirium: Are We There Yet?

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2017English

Cancer Immunotherapy: Are We There Yet?

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2013English

Clinical Proteomics: Are We There Yet?

Analytical Chemistry
Analytical Chemistry
2003English

Personalized Medicine: Are We There Yet?

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2008English

Safe Cell and Gene Therapy Combination: Are We There Yet in Arthritis?

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Are We Half-Way There Yet?

Journal of Education for Sustainable Development
2009English

Personalized Cancer Medicine: Are We There Yet?

Oncologist
Cancer ResearchMedicineOncology
2013English

Corticosteroids for Pneumonia: Are We There Yet?

Respirology
PulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy